Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
J Coll Physicians Surg Pak ; 31(10): 1168-1173, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34601836

ABSTRACT

OBJECTIVE: To describe the baseline characteristics and two-year outcomes of patients with Child-Pugh grades A and B cirrhosis; and evaluate the predictive value of liver stiffness for the development of adverse outcomes (AOs) in this patient population. STUDY DESIGN: A prospective cohort study. PLACE AND DURATION OF STUDY: The Second Hospital, Cheeloo College of Medicine, Shandong University, China between September 2018 and March 2021. METHODOLOGY: The present study consecutively included patients with Child-Pugh grades A and B cirrhosis. Patients were followed up every six months until two years. Baseline demographic characteristics and laboratory indexes were collected. Liver stiffness and controlled attenuation parameter were measured at baseline, month 6 and month 12. The observational endpoint was AOs, including liver-related patient death and hepatocellular carcinoma (HCC). RESULTS: A total of 174 patients were included in the final cohort. Hepatitis B virus (HBV)-induced liver cirrhosis accounted for the vast majority of enrolled cases (82.2%). AOs were observed in six patients. Multivariate logistic regression model was performed and liver stiffness was considered as the only independent predictor for AOs (OR 1.071, p = 0.006). Liver stiffness was also significantly improved at 12 months compared with the baseline data (median 10.6 vs. 13.3 kPa, p <0.001). CONCLUSION: Patients with Child-Pugh grades A and B cirrhosis had an acceptable short-term prognosis. Greater liver stiffness predicted two-year AOs in these patients with relatively mild cirrhosis. The prognostic value of changes in liver stiffness warrants further investigation. Key Words: Liver cirrhosis, Child-Pugh score, Liver stiffness, Asian population, Outcome.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Humans , Liver Cirrhosis/complications , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL